PRODUCT DESCRIPTION:

Succinylcholine Chloride Injection is a rapid-onset, short-acting depolarizing neuromuscular blocker widely used to facilitate endotracheal intubation and provide skeletal muscle relaxation during surgery or mechanical ventilation.

Its action mimics acetylcholine at the neuromuscular junction, resulting in brief muscle fasciculations followed by flaccid paralysis.

Due to its fast onset (within 30–60 seconds) and short duration of action (4–6 minutes), it is preferred in emergency situations requiring immediate airway control.

This formulation ensures consistent potency and stability, meeting stringent global quality standards.

Formulation & Presentation:

• Dosage Form: Sterile Injectable
• Presentation: Clear Sterile Solution in Clear/Amber Glass Vial/ Ampoule (customizable as per market demand)
• Available Strengths:
  • Succinylcholine Chloride Injection: 50 MG/ ML
• Route of Administration: Via Intravenous (IV) Bolus Injection or Intramuscular (IM) Injection routes or as advised by physician. To be used after appropriate reconstitution or as per clinical indication and recommendation. Reconstituted as per protocol for injection in country of use. To be administered under strict supervision of a qualified doctor or as per physician’s discretion or decision only.

Therapeutic Indications:

• Facilitating endotracheal intubation
• Providing skeletal muscle relaxation during surgeries
• Assisting in mechanical ventilation during emergency airway management
• Electroconvulsive therapy (ECT) procedures

Side Effects:

• COMMON:
  • Muscle fasciculations
  • Postoperative muscle pain
  • Transient apnea
  • Increased intraocular or intracranial pressure
• SERIOUS (RARE):
  • Malignant hyperthermia (potentially fatal)
  • Severe hyperkalemia (especially in burn or trauma patients)
  • Bradycardia or cardiac arrest
  • Anaphylaxis or hypersensitivity reactions
  • Prolonged paralysis in patients with pseudocholinesterase deficiency
• PRECAUTIONS:
  • Reserved for use by clinicians trained in airway management
  • Should be administered with facilities for artificial ventilation
  • Avoid in patients with known or suspected hyperkalemia
  • Contraindicated in those with history of malignant hyperthermia or recent major trauma/burns
  • Monitor for bradycardia, especially in pediatric or repeat doses